| 产品描述: | LY2940094 (BTRX-246040) tartrate 是一种高效、可透过大脑的、选择性、口服的 NOP 受体拮抗剂,具有高亲和力 (Ki=0.105 nM) 和拮抗作用 (Kb=0.166 nM)。LY2940094 tartrate 可减少动物模型中的乙醇自我给药和寻求乙醇。 |
| 靶点: |
Ki: 0.105 nM (NOP receptor);Kb: 0.166 nM (NOP receptor) |
| 体内研究: |
LY2940094 (3, 10, or 30 mg/kg; orally daily for 4 days) dose-dependently reduces homecage ethanol self-administration in Indiana Alcohol-Preferring (P) and Marchigian Sardinian Alcohol-Preferring (msP) rats, without affecting food/water intake or locomotor activity. |
| 参考文献: |
1. Rorick-Kehn LM, et al. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models. Alcohol Clin Exp Res. 2016 May;40(5):945-54. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.585 ml |
7.923 ml |
15.847 ml |
| 5 mM |
0.317 ml |
1.585 ml |
3.169 ml |
| 10 mM |
0.158 ml |
0.792 ml |
1.585 ml |
| 50 mM |
0.032 ml |
0.158 ml |
0.317 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |